C07D 473 - Heterocyclic compounds containing purine ring systems

Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/2006
11/15/2006	EP1720877A2 Aryl substituted purine analogues
11/15/2006	EP1720876A1 Crystalline forms of valacyclovir hydrochloride
11/15/2006	EP1720875A1 8- [3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
11/15/2006	EP1720874A1 4-substituted piperidine derivatives
11/15/2006	EP1720840A2 Methods to manufacture 1,3-dioxolane nucleosides
11/15/2006	CN1861602A Preparation process of entecavir
11/15/2006	CN1861601A Process for preparing optics pure abacavir
11/15/2006	CN1861078A Human AGT protein micromolecular inhibitor
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135475 Antidiabetic agents
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/09/2006	WO2006119507A2 Non-nucleotide composition and method for inhibiting platelet aggregation
11/09/2006	WO2006117670A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
11/09/2006	US20060252776 Novel crystalline forms of valacyclovir hydrochloride
11/09/2006	US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006	CA2607780A1 Purine derivatives
11/08/2006	EP1719772A1 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
11/08/2006	EP1719765A1 Novel sulfone amide derivative
11/08/2006	CN1860364A Fluorescently tagged ligands
11/08/2006	CN1860120A Amorphous valganciclovir hydrochloride
11/08/2006	CN1860119A Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction
11/07/2006	US7132426 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/07/2006	CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006	WO2006114575A1 Novel development accelerator-releasing couplers
11/02/2006	WO2006114492A1 Method for preparing optically active hydroxypropylened adenine
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247226 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
11/02/2006	EP1058686B1 2'-fluoronucleosides
11/01/2006	CN1856496A HIV-replikasjonshemmede purinderivater
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129244 Triazolopyrimidines and related analogs as HSP90-inhibitors
10/31/2006	US7129239 Dietetics; cardiovascular disorders; strokes; antidiabetic agents, sleep disorders, osteoporosis
10/31/2006	CA2256545C Probe for analysis of nucleic acids
10/31/2006	CA2247419C Oxazole derivatives, their production and use
10/31/2006	CA2214670C 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives
10/26/2006	US20060241120 Cannabinoid Receptor Ligands and Uses Thereof
10/25/2006	EP1287532A4 Method for producing ?18 f\|fluoride ion
10/24/2006	US7126001 Antiproliferative agents; antitumor agents
10/24/2006	US7125994 PNA monomer and precursor
10/24/2006	US7125993 A2B adenosine receptor antagonists
10/24/2006	US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/24/2006	CA2245383C Famciclovir monohydrate
10/19/2006	WO2006108640A1 Phenylacetamides suitable as protein kinase inhibitors
10/19/2006	WO2006108482A1 Purine derivatives as receptor-tyrosine kinase activityinhibitors
10/19/2006	US20060235224 Process for preparing 2.6-dichloropurine
10/19/2006	US20060234974 2,6-Dihalogeno-8-substituent-purine compound and process for producing the same
10/19/2006	DE102005017259A1 Purinderivate Purine derivatives
10/19/2006	CA2604294A1 Purine derivatives as inhibitors of receptor tyrosine kinase activity
10/19/2006	CA2603941A1 Phenylacetamides suitable as protein kinase inhibitors
10/18/2006	EP1534255A4 Processes for preparing 1,3-dioxolane nucleosides
10/18/2006	EP1515970B1 Alkynylpurine compounds and production methods thereof
10/18/2006	EP1084710B1 Adenosine a1 antagonists for male sterility
10/18/2006	CN1849126A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/17/2006	US7122693 Acetaldehyde acetal compounds, their synthesis, and uses thereof
10/17/2006	US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006	US7122665 Heterocyclic compounds
10/17/2006	US7122539 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications.
10/12/2006	WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/12/2006	US20060229322 Anhydrous crystalline form of valacyclovir hydrochloride
10/12/2006	US20060229294 Benzisothiazoles useful for treating or preventing HCV infection
10/11/2006	EP1709967A1 Agents for treating migraine
10/11/2006	EP1709966A1 Preventive and/or therapeutic agent for higher brain dysfunction
10/11/2006	EP1709049A1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
10/11/2006	CN1845742A Method of stabilizing diarylvinylene compound
10/10/2006	US7119202 Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties
10/10/2006	CA2280730C Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
10/10/2006	CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
10/05/2006	WO2006076595A8 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/05/2006	WO2005085470A9 Specific substrates for o6- alkylguanine-dna alkyltransferase
10/05/2006	US20060223835 2' and 3'- substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation
10/05/2006	US20060223784 Method and compositions for temporarily incapacitating subjects
10/04/2006	EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/04/2006	EP1707207A2 Use of a food additive comprising theobromine for the prevention of colon, gastric or liver cancer
10/04/2006	EP1706406A1 Process for the preparation of valacyclovir hydrochloride
10/04/2006	EP1706405A1 4'-substituted carbovir- and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
10/04/2006	CN1277807C Process for the preparation of aminoalcohol and (1S, 4Rú®or (1R, 4S)-1-amino-4-(methylol)-2-cyclopentene or its salts
10/03/2006	US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006	US7115741 Anticoagulants and antiagglomerants
10/03/2006	US7115739 Triazole compounds useful as protein kinase inhibitors
10/03/2006	US7115661 Methods and compositions for mitigating pain
10/03/2006	US7115616 Pyrimidinone compounds
10/03/2006	CA2213188C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
09/2006
09/28/2006	WO2006100520A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
09/28/2006	CA2602395A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
09/27/2006	EP1173222B1 Conjugate having a cleavable linkage for use in a liposome
09/27/2006	CN1837206A Sesquiterpene subergorgia suberosa ketone and its preparing process and application
09/21/2006	WO2006099204A1 Substituted 9-alkyladenines and the use thereof
09/21/2006	WO2006097260A1 Adenosine derivatives having a2a receptor activity
09/21/2006	US20060211862 Biotechnological resolution of racemic mixtures of 1-Amino-4-(hydroxymethyl)-2-cyclopentene using a hydrolase (lipase); optional formation of acyl derivatives
09/21/2006	US20060211855 Method for the production of oh protected{4-(2.6-diamino-9h-purine-9-yl)-1.3-dioxolane-2-yl] methanol derivatives
09/21/2006	US20060211713 Compounds having selective hydrolytic potentials
09/21/2006	US20060211695 Fused heterocyclic kinase inhibitors
09/21/2006	US20060211045 Fluorescently tagged ligands
09/21/2006	CA2601032A1 Substituted 9-alkyladenines and the use thereof
09/21/2006	CA2598865A1 Adenosine derivatives having a2a receptor activity
09/20/2006	EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006	EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006	CN1835952A Compounds and compositions as inhibitors of receptor tyrosine kinase activity
09/19/2006	US7109330 {(2-hydroxyethyl)[9-(methylethyl)-6-(3-quinolylamino)purin-2-yl]amino}ethan-1-ol; antiproliferatives, treating rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis, host graft disease, and gout

1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 120